EGFR C797S | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

23 September 2024

Black Diamond joins ArriVent in the PACC pack

BDTX-1535 takes aim at PACC mutations and Tagrisso resistance.

Subscribe to EGFR C797S